Royal Sense Share Pledge
Promoter Rishabh Arora released 10,00,000 shares (18.69%) from pledge to Comfort Securities Limited. His total holding in Royal Sense remains at 61.50%.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements with these filters
Promoter Rishabh Arora released 10,00,000 shares (18.69%) from pledge to Comfort Securities Limited. His total holding in Royal Sense remains at 61.50%.
Royal Sense Limited has submitted its Annual Report for FY 2025-26 to the exchange. The 3rd Annual General Meeting is scheduled for September 28, 2026.
Royal Sense Limited has issued a notice for its 3rd Annual General Meeting scheduled for September 28, 2026, to conduct its ordinary and special business.
Royal Sense Limited re-appointed Mr. Rishabh Arora as Managing Director for a three-year term, subject to shareholder approval. The Board also approved the 3rd Annual General Meeting.
Royal Sense Limited clarified that recent stock price movements are due to market conditions, with no undisclosed price-sensitive information affecting the company at this time.
Royal Sense approved a ₹500 Crore fund raise via debt or equity-linked instruments. The board also proposed doubling authorized share capital to ₹20 Crore.
Royal Sense Limited scheduled a board meeting for July 17, 2026. The agenda includes considering a fund raise and increasing the company's authorized share capital.
Royal Sense Limited appointed Ms. Somya Arora as Company Secretary and Key Managerial Personnel. The appointment is effective from July 13, 2026.
Promoter Rishabh Arora pledged 10 lakh shares in Royal Sense Ltd. The pledge, for financial assistance, affects 18.69% of the total share capital.
Company Secretary and Compliance Officer Ms. Prachi Agnihotri has resigned. Her resignation is effective from June 27, 2026.
Royal Sense Ltd reported revenue from operations of ₹59.9 Cr (+50.9% YoY) and net profit of ₹3.1 Cr (-22.5% YoY) for H2 FY26.
Royal Sense Limited approved its audited standalone and consolidated financial results for fiscal year 2026. The board meeting also approved committee formations and employee stock option revisions.
Royal Sense Limited confirmed non-applicability of the Annual Secretarial Compliance Report for FY2026. The exemption applies due to the company's listing on the BSE SME platform.
Royal Sense Ltd scheduled a board meeting for May 25, 2026, to approve audited annual financial results. Directors will also consider revisions to employee stock options.
Royal Sense Limited launched seven new pharmaceutical products and a digital blood pressure monitor for the domestic market. The expansion strengthens its healthcare product portfolio.
Royal Sense Limited appointed CS Prachi Agnihotri as Company Secretary and Compliance Officer. Effective May 19, 2026, she brings professional expertise to the management team.
Royal Sense Limited clarified that it does not meet the criteria for 'Large Corporate' classification for FY2026. The company reported outstanding long-term borrowings below the ₹1,000 Crore threshold and does not possess the required credit rating. This regulatory filing confirms the company is exempt from mandatory incremental debt sourcing through the bond market.
Royal Sense Ltd launched 17 new pharmaceutical products, including Vitamin D3 shots, multivitamins, liver tonics, and dermatological creams. Available for sale from April 27, 2026, these products cater to the domestic market. This expansion significantly broadens the company's healthcare portfolio across high-growth nutraceutical and therapeutic segments.
Royal Sense Ltd clarified to the BSE that recent share price fluctuations are purely market-driven and speculative. The company confirmed it has disclosed all material information under Regulation 30 and no price-sensitive information remains undisclosed.